Statements (27)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:company
abbreviation vaccine |
| gptkbp:abbreviation |
gptkb:Bacillus_Calmette-Guérin
|
| gptkbp:administeredBy |
humans
injection |
| gptkbp:CEO |
gptkb:Christoph_Schweizer
|
| gptkbp:developedBy |
gptkb:Camille_Guérin
gptkb:Albert_Calmette |
| gptkbp:firstReleased |
1921
|
| gptkbp:foundedYear |
1963
|
| gptkbp:founder |
gptkb:Bruce_Henderson
|
| gptkbp:fullName |
gptkb:Boston_Consulting_Group
|
| gptkbp:globalPresence |
over 50 countries
|
| gptkbp:headquartersLocation |
gptkb:Boston,_Massachusetts,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
BCG
|
| gptkbp:industry |
management consulting
|
| gptkbp:notableFor |
gptkb:BCG_matrix
business strategy consulting |
| gptkbp:numberOfEmployees |
over 25,000
|
| gptkbp:type |
live attenuated vaccine
|
| gptkbp:usedFor |
tuberculosis prevention
|
| gptkbp:usedIn |
bladder cancer treatment
|
| gptkbp:website |
https://www.bcg.com/
|
| gptkbp:WHOStatus |
gptkb:World_Health_Organization's_List_of_Essential_Medicines
|
| gptkbp:bfsParent |
gptkb:Boston_Consulting_Group
|
| gptkbp:bfsLayer |
5
|